ACADEMIC AND INDUSTRY HEALTH ALLIANCE TACKLE TOMORROW’S NATIONAL HEALTH CHALLENGES TODAY Trends report identifies prototyping targets for breakthroughs in digital and hybrid futures
With
Vishaal Kishore,
Professor of Innovation and Public Policy
RMIT University &
Executive Chair, RMIT-Cisco Health Transformation Lab &
Director – Impact, RMIT University, Melbourne
AUSTRALIAN HEALTH JOURNAL SEGMENT
Filmed in Melbourne | June 2025
Vishaal Kishore, a Professor of Innovation and Public Policy at RMIT in Melbourne, serves as the Executive Chair of the RMIT-Cisco Health Transformation Lab and RMIT’s Director of Impact. Led by the RMIT-Cisco Health Transformation Lab, the National Industry Innovation Network (NIIN) Health Alliance combines the best minds, technologists, industry capabilities and academic resources to solve pressing industry and social challenges through technology-driven innovation. The NIIN aims to pool insights and expertise to address national health challenges, marking its first vertical focus on health.
Last year a “Sandbox” was established to serve as a digitally rich collaboration and prototyping studio designed for privacy and security, ready to innovate in aged care and healthcare. The “Sandbox” housed at RMIT-Cisco’s Health Transformation Lab is a digitally-enabled mock care setting where researchers, startups and health system professionals work together on prototypes for the future of health. The Sandbox enables a frictionless pipeline from idea to implementation. The inclusion of autonomous robotics, has created a space where the most futuristic visions for health can be trialled, tested, and translated into practice.
The Health Transformation Lab emphasises user engagement, prioritising the voices of clients and clinicians to design solutions based on their needs rather than assumptions. This practice aims to ensure that any technology developed gains traction in health systems only if it genuinely reflects user requirements.
The NIIN Health Alliance has identified urgent needs in the healthcare system, considering the rapidly evolving technological landscape. As part of their strategic planning, they reviewed nearly 10,000 articles and reports to outline pivotal trends for the future in the publication “Health x Digital Transformation Report 2024-2025”.
In this report, a significant focus has been on the implications of augmented intelligence, remote patient monitoring, digital simulations, adaptable systems, and leveraging advancements in biotechnology, aiming to prepare the healthcare sector for emerging challenges and opportunities in the coming years.
Source: Written from transcript and health transformation lab website by AUDIENCED
-
New Generative AI and machine learning frontier on unused patient care data
Drawing from GE’s 125-year legacy in healthcare, Amit Yadav, CEO GE HealthCare ANZ is leading efforts to integrate AI into medical imaging devices and optimise workflow efficiencies. He stresses the importance of leveraging the vast amount of untapped healthcare data, with an emphasis on automating manual processes to enhance productivity. Additionally, his focus extends to utilising AI for workflow optimisation and ensuring compliance with local regulations and standards to prioritise safety.
-
Imperatives for women diagnosed with ovarian cancer
Professor Clare Scott, a pioneering clinician scientist at the Walter and Eliza Hall Institute of Medical Research in Melbourne, also serves as a medical oncologist at Peter MacCallum Cancer Centre, the Royal Melbourne Hospital, and the Royal Women’s Hospital.
Her comprehensive training in medical oncology has fuelled her specialisation in gynaecological cancer, combining rigorous research with clinical trials to improve patient outcomes. With over a decade of involvement in ANZGOG, Australia’s foremost gynaecologic cancer research organisation, she is deeply committed to advancing research and saving lives.
-
New treatment options under investigation for pelvic organ prolapse
Dr Shayanti Mukherjee, Research Group Head, Translational Tissue Engineering at the with her team at Hudson Institute of Medical Research is developing new ways to prevent and potential cure pelvic organ prolapse (POP). The technology aims to ultimately lead to safer and more effective treatment for women with pelvic organ prolapse (POP) using a woman’s own stem cells to boost the effectiveness of a degradable mesh.
